Status:
UNKNOWN
Bioequivalence Study for the Safety and the Pharmacokinetics of DWJ1558 in Healthy Adult Volunteers
Lead Sponsor:
Daewoong Pharmaceutical Co. LTD.
Conditions:
Healthy Volunteers
Eligibility:
All Genders
19+ years
Phase:
PHASE1
Brief Summary
This study aims to compare the pharmacokinetics and safety following administration of DWJ1558 and co-administration of DWC202310 and DWC202311 in healthy volunteers.
Eligibility Criteria
Inclusion
- over 19 year old
Exclusion
- Pancreatitis
- Diabetic ketoacidosis
Key Trial Info
Start Date :
August 17 2023
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
January 1 2024
Estimated Enrollment :
66 Patients enrolled
Trial Details
Trial ID
NCT06010589
Start Date
August 17 2023
End Date
January 1 2024
Last Update
August 30 2023
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
H Plus YANGJI Hospital
Seoul, South Korea